The Effects of Seasonal Changes in Osteoporosis Treatment
NCT02977949 · Status: UNKNOWN · Type: OBSERVATIONAL · Enrollment: 200
Last updated 2016-11-30
Summary
There are few reports concerning to the seasonal variation of osteoporosis treatment. In this study, we plan to compare clinical efficacy and safety by seasons.
Conditions
- Selective Estrogen Receptor Modulator (SERM)
Interventions
- DRUG
-
Raloxifene
Sponsors & Collaborators
-
Toshihiko Kono
lead OTHER
Principal Investigators
-
Rui Niimi, MD · Tomidahama Hospital
Eligibility
- Min Age
- 45 Years
- Max Age
- 100 Years
- Sex
- FEMALE
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2012-01-31
- Primary Completion
- 2018-07-31
- Completion
- 2019-12-31
Countries
- Japan
Study Locations
More Related Trials
-
Anabolic Therapy in Postmenopausal Osteoporosis
NCT05010590 ·Status: ACTIVE_NOT_RECRUITING ·Phase: PHASE4
-
Efficacy, Safety and Tolerability of Romosozumab in the Treatment of Japanese Women With Postmenopausal Osteoporosis
NCT01992159 ·Status: COMPLETED ·Phase: PHASE2
-
ONO-5920/YM529 Confirmatory Study in Involutional Osteoporosis Patients
NCT00794443 ·Status: COMPLETED ·Phase: PHASE2/PHASE3
-
Teriparatide (Forsteo) Treatment in Postmenopausal Women: Mechanism of Action
NCT01293292 ·Status: COMPLETED ·Phase: PHASE4
-
Effect of Vitamin D and Denosumab on Bone Remodelling in Women With Postmenopausal Osteoporosis
NCT05372224 ·Status: COMPLETED ·Phase: NA
-
A Phase I Study of AK159 in Healthy Postmenopausal Women
NCT01935479 ·Status: COMPLETED ·Phase: PHASE1
-
Efficacy and Safety of Actonel® After Denosumab Discontinuation in Postmenopausal Osteoporosis Women
NCT05630768 ·Status: COMPLETED ·Phase: PHASE4
-
Effects of Cycle Therapy vs Sequential Therapy With Romosozumab and Denosumab in Postmenopausal Osteoporosis Patients
NCT06938152 ·Status: RECRUITING ·Phase: PHASE4
-
Continuation of Anti-osteoporotic Treatment 1 Year After Initial Administration
NCT06024148 ·Status: UNKNOWN
-
A Comparison Study With Alendronate and Raloxifene in Postmenopausal Women With Osteoporosis (0217-189)
NCT00389740 ·Status: COMPLETED ·Phase: PHASE3
-
A Study to Test the Efficacy, Safety and Tolerability of Romosozumab Treatment in Postmenopausal Chinese Women With Osteoporosis
NCT05067335 ·Status: COMPLETED ·Phase: PHASE3
-
Intervention Study of Drugs in Patients Osteopenia and Osteoporosis
NCT04719572 ·Status: UNKNOWN ·Phase: NA
-
A Study of SB751689 in Japanese Postmenopausal Women
NCT00554255 ·Status: COMPLETED ·Phase: PHASE1
-
An Observational Study Assessing Effects in Patients With Combination Therapy With Raloxifene/Cholecalciferol
NCT04788290 ·Status: COMPLETED
-
Satisfaction and Compliance of Risedronate in PMO
NCT00549965 ·Status: COMPLETED ·Phase: PHASE4
-
Effect of Denosumab on Inflammatory Osteolytic Lesion Activity in Total Hip Arthroplasty
NCT01358669 ·Status: COMPLETED ·Phase: PHASE2
-
Clinical Study of AK159 in Healthy Postmenopausal Women
NCT01551602 ·Status: COMPLETED ·Phase: PHASE1
-
Enhancing Osteoporosis Therapy: Can We Open the Anabolic Window?
NCT01166958 ·Status: COMPLETED ·Phase: PHASE4
-
Raloxifene for Prevention of Bone Loss in Postmenopausal Patients Receiving Chronic Corticosteroid Therapy
NCT00371956 ·Status: COMPLETED ·Phase: PHASE4
-
Proof of Concept (Bone Resorption/Bone Mineral Density) Study (0429-005)
NCT00533650 ·Status: COMPLETED ·Phase: PHASE2
-
Denosumab for Prevention of Osteoporosis in Renal Transplant Recipients
NCT01377467 ·Status: COMPLETED ·Phase: PHASE3
-
Clinical Results of Bisphosphonate and Denosumab Therapy Following Teriparatide Therapy for Japanese
NCT02166437 ·Status: UNKNOWN
-
Precision Medicine Approach for Osteoporosis - Follow Up Study
NCT06264609 ·Status: ENROLLING_BY_INVITATION ·Phase: PHASE4
-
Drug Holidays in the Treatment With Alendronate in Postmenopausal Women With Osteoporosis
NCT00936260 ·Status: COMPLETED ·Phase: NA
-
2-Year Therapy With Teriparatide vs 1-yr Therapy Followed by 1-Year of Raloxifene or Calcium/Vit D in Severe Postmenopausal Osteoporosis
NCT00191425 ·Status: COMPLETED ·Phase: PHASE4